Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Shares Outstanding (Diluted Average) (2021 - 2024)

Historic Shares Outstanding (Diluted Average) for LifeStance Health (LFST) over the last 4 years, with Q4 2024 value amounting to $379.1 million.

  • LifeStance Health's Shares Outstanding (Diluted Average) rose 318.13% to $379.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $379.1 million, marking a year-over-year increase of 318.13%. This contributed to the annual value of $379.1 million for FY2024, which is 318.13% up from last year.
  • Latest data reveals that LifeStance Health reported Shares Outstanding (Diluted Average) of $379.1 million as of Q4 2024, which was up 318.13% from $380.4 million recorded in Q3 2024.
  • LifeStance Health's 5-year Shares Outstanding (Diluted Average) high stood at $380.4 million for Q3 2024, and its period low was $327523.0 during Q4 2021.
  • In the last 4 years, LifeStance Health's Shares Outstanding (Diluted Average) had a median value of $363.2 million in 2023 and averaged $256.6 million.
  • As far as peak fluctuations go, LifeStance Health's Shares Outstanding (Diluted Average) skyrocketed by 10837421.4% in 2022, and later soared by 211.64% in 2024.
  • Over the past 4 years, LifeStance Health's Shares Outstanding (Diluted Average) (Quarter) stood at $327523.0 in 2021, then skyrocketed by 108374.21% to $355.3 million in 2022, then grew by 3.43% to $367.5 million in 2023, then increased by 3.18% to $379.1 million in 2024.
  • Its last three reported values are $379.1 million in Q4 2024, $380.4 million for Q3 2024, and $379.4 million during Q2 2024.